Globally, the blow fill seal equipment market is expected to rise with a CAGR of 6.2% during the forecast period, from US$ 337.3 Mn in 2020. The growth of this market is driven by the increasing demand for blow fill seal technology across pharmaceutical companies across the globe. Pharmaceutical companies are leveraging this technology for the packaging and storage of medicines. The high aseptic packaging nature of the technology along with the high speed of the operation makes it a suitable option for the pharmaceutical packaging.
Globally, the stretch blow molding machines market is expected to grow with a CAGR of 2.8% during the forecast period from 2021 to 2029, starting from US$755.6 Mn in 2020. The stretch blow molding machines are used for the production of containers and plastic bottles. At present, these machines are specially used in the manufacturing of soda bottles. These machines enable reliable manufacturing processes including bottle design, bottle molds, air preparation, and others.
Globally, the pressure reducing valve market is expected to grow with a CAGR of 4.2% through the forecast period, up from US$1.75 Bn in 2020. The growth of the market is attributed to the increasing adoption of the pressure reducing valves across the wide range of application across several industry verticals. The valves are widely used to maintain and relieve the pressure of the gas and fluids. The valve reduces the frequency of the unstable pressure and maintains a constant pressure via spring mechanism.
The capacitors for medical electronics market worldwide is estimated to grow with a CAGR of 6.9% through the forecast period starting from 2021 to 2029. Medical electronics market worldwide is observing continued growth over the past few years with more than 3.8% growth rate every year.
Globally, the direct-to-shape inkjet printing market is expected to grow with a CAGR of 6.3% during the forecast period from 2025 to 2033. At present, direct-to-shape inkjet printing is changing the packaging industry. This technology enables the printing of images and the texts directly on objects such as bottles, cans and other products. Along with the package decoration, it also helps to provide valuable information about the products.
The global spinal muscular atrophy treatment market is growing proficiently, expected to grow at a CAGR of 14.5%. Globally, the increasing incidence of SMA along with improved treatment management by innovative gene therapy and drugs will drive the growth of the market. Increasing awareness, FDA approval for new drugs, partnerships for enhanced R&D and private funding will boost the overall demand of SMA treatment on a global scale.
The hypoactive sexual desire disorder treatment market is set to expand at a compounded annual growth rate (CAGR) of 5.2% during the forecast period from 2019 to 2027. Hypoactive sexual desire disorder (HSDD) can be primary, secondary, lifelong or situational; currently physicians worldwide are employing either psychotherapy or pharmacotherapy for its treatment. Recent approval of Bremelanotide (Vyleesi) will propel the HSDD market growth in the near future. Currently 2 drugs such as Prasterone 6.5 mg vaginal insert and BP101 are under phase 3 clinical trial being investigated for its safety and efficacy for treating HSDD.
Neutropenia treatment accounted for a market value of US$ 12,971.08 Mn in 2021 and projected to grow at a CAGR of 5.0% during the forecast period from 2025 to 2033. In neutropenia count of neutrophil falls giving rise to compromised immunity further increasing the risk of infection. Neutropenia is observed in almost half cases of cancer patients being treated with chemotherapy but out of them most are suffering from leukaemia.
Globally, the cognitive assessment and training market is expected to grow with a CAGR of 32.0% during the forecast period from 2019 to 2027, up from US$ 3.42 Bn in 2018. This market growth is attributed to the increasing elderly population across the globe. The population aging more than 60 years is growing rapidly worldwide. In 2015, more than 600 Mn populations across the globe were aging more than 60 years and it is estimated to increase cross the 2 Bn mark by 2050. The sudden increase in the life expectancy rate and sudden decline in the infertility rate is driving the growth of the geriatric population.
Devic’s syndrome (Neuromyelitis optica) treatment accounted for a market value of US$ 217.7 Mn in 2021 and projected to grow at a CAGR of 12.0% during the forecast period from 2025 to 2033. Devic's disease or neuromyelitis optica is an autoimmune disease in which antibodies and immune system cells mainly damage the optic nerves and the spinal cord, but in a few cases affect the brain.
The drugs by therapeutic area include therapy for oncology, cardiovascular, central nervous system, infectious diseases, respiratory, and others. The therapeutic area represents the specific area of medicine where the drug is intended to be used, based on its mechanism of action and intended clinical use. One of the primary drivers of the drugs by therapeutic area market is the increasing prevalence of diseases worldwide. Chronic diseases such as cancer, cardiovascular diseases, and neurological disorders are a significant burden on healthcare systems globally. There is an urgent need for new and effective therapies to treat these diseases, which has led to the growth of the drugs in the therapeutic area market.
The revenues generated by the drugs in the therapeutic area market have been consistently high over the years. The global pharmaceutical market is expected to reach USD 1.5 trillion by 2023, with oncology being the leading therapeutic area. The increasing demand for new therapies, coupled with advancements in technology and an increasing focus on personalized medicine, is expected to drive the growth of the market in the coming years. One of the emerging trends in the drugs by therapeutic area market is the increasing use of precision medicine. Precision medicine involves tailoring medical treatments to individual patients based on their unique genetic and molecular profiles. The development of precision medicine requires the use of advanced diagnostic tools and drug discovery technologies, which have contributed to the growth of drugs in the therapeutic area market.
Another trend in the drugs by therapeutic area market is the increasing focus on biologics. Biologics are drugs that are produced from living cells and are used to treat a wide range of diseases, including cancer and autoimmune disorders. Biologics are more complex than traditional small-molecule drugs, and their development requires specialized manufacturing processes and clinical trial design. The increasing demand for biologics has contributed to the growth of the drugs by therapeutic area market. The increasing focus on rare diseases is also driving the growth of the drugs by therapeutic area market. Rare diseases are defined as diseases that affect fewer than 200,000 people in the United States. Although each rare disease affects a small number of people, there are over 7,000 rare diseases, which together affect millions of people worldwide. There is an urgent need for new therapies to treat rare diseases, which has led to the growth of drugs in the therapeutic area market.
The increasing use of combination therapies is driving the growth of the drugs by therapeutic area market. Combination therapies involve the use of two or more drugs to treat a disease. Combination therapies can improve patient outcomes by targeting multiple pathways involved in the disease process. The development of combination therapies requires the use of advanced drug discovery technologies and clinical trial design, which has contributed to the growth of the drugs by therapeutic area market. The increasing prevalence of diseases worldwide, advancements in technology, and the emerging trends in precision medicine, biologics, rare diseases, and combination therapies are expected to drive the growth of the drugs by therapeutic area market.
